Analyst Ratings for Valeant Pharmaceuticals (VRX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/12/2011 | Morgan Stanley | N/A | New Coverage | Equalweight (N/A) |
N/A (N/A) |
40.91 (45.33) |
10.8% | Details |
| 5/10/2011 | Goldman Sachs | N/A | New Coverage | Neutral (N/A) |
N/A (N/A) |
51.88 (45.33) |
-12.63% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
